Farmacología

2008

1. AN AMPA/KAINATE RECEPTOR-TRIGGERED NA(+)-DEPENDENT K+ CURRENT MEDIATES POST-ACTIVATION INHIBITION INDUCED BY GLUTAMATE IN RAT LOCUS COERULEUS NEURONS

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2. ANATOMICAL DISTRIBUTION OF LIPID SPECIES INVOLVED IN NEUROTRANSMISSION USING IMAGING MASS SPECTROMETRY

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

3. CANNABINOID CBI RECEPTOR EXPRESSION AND FUNCTIONALITY IN POSTMORTEM BRAIN OF ALCOHOLIC SUBJECTS

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

4. CEREBRAL MICRODIALYSIS IN CLINICAL PRACTICE: CHEMICAL MARKERS IN A MODEL FOR ACUTE FOCAL ISCHEMIA IN THE HUMAN BRAIN

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

5. COMPARISON OF GENE EXPRESSION PATTERNS IN CEREBRAL CORTEX BETWEEN THREE DIFFERENT ANIMAL MODELS OF DEPRESSION

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

6. EFFECT OF Delta(9)-TETRAHIDROCANNABINOL ON THE SUBTHALAMO-NIGRAL PATHWAY

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

7. EFFECTS OF SUBCHRONIC CORTICOSTERONE TREATMENT IN THE FUNCTIONAL ACTIVITY OF ALPHA 2-ADRENOCEPTORS IN RAT BRAIN CORTEX

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

8. ELECTROPHYSIOLOGICAL PROPERTIES AND EFFECTS OF ANTIDEPRESSANTS ON LOCUS COERULEUS ACTIVITY: AN IN VIVO STUDY IN WILD-TYPE AND GIRK2 MUTANT MICE

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

9. FUNCTIONAL CROSS-TALK BETWEEN ADENOSINE A(1) AND A(2A) RECEPTORS IN HUMAN BRAIN STRIATAL MEMBRANES

   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

10. G PROTEIN COUPLING OF GALANIN AND MUSCARINIC RECEPTORS IN POSTMORTEM BRAIN SLICES OF ALZHEIMER'S DISEASE PATIENTS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

11. IDENTIFICATION OF MOLECULAR MARKERS AND THERAPEUTIC TARGETS IN SCHIZOPHRENIA BY DNA MICROARRAYS IN POSTMORTEM HUMAN BRAIN

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

12. IMPLEMENTATION OF THE VIRTUAL PLATFORM MOODLE IN A CLINICAL PHARMACOLOGY COURSE FOR MEDICAL STUDENTS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

13. LEVODOPA ALTERS THE ANTI DEPRESSANT-LIKE EFFECT OF FLUOXETINE AND REBOXETINE IN THE MODIFIED FORCED SWIMMING TEST IN RATS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

14. ORGANOTYPIC CULTURE EX VIVO MODEL FOR THE STUDY OF THE INTEGRITY OF CHOLINERGIC PATHWAYS IN ALZHEIMER'S DISEASE RESEARCH

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

15. PHARMACOLOGICAL EVALUATION OF GUANIDINE AND 2-AMINOIMIDAZOLINE AROMATIC DERIVATIVES AS alpha(2)-ADRENOCEPTOR ANTAGONISTS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

16. PHOSPHORYLATION OF FADD, MAPKs AND PEA-15 IN BRAINS OF OPIATE ADDICTS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

17. PRESENCE OF alpha(2C) DEL322-325 ADRENOCEPTOR GENE POLYMORPHISM IN SUBJECTS WITH DIFFERENT PSYCHIATRIC DISORDERS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

18. ROLE OF SEROTONERGIC RECEPTORS LOCATED IN THE LOCUS COERULEUS ON THE IN VIVO MODULATION OF THE RAT'S CENTRAL NORADRENERGIC SYSTEM

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

19. ROLE OF TOTAL AND UNBOUND PLASMA CONCENTRATIONS OF TACROLIMUS IN CLINICAL OUTCOME

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

20. THE ROLE OF TRYPTOPHAN HYDROXYLASE 2 (TPH-2) GENE POLYMORPHISMS IN THE PATHOGENESIS OF COMPLETED SUICIDE

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY